Univariate analyses
|
MiR-425 (high vs. low)
|
1.037 (0.624–1.724)
|
0.888
|
1.073 (0.626–1.840)
|
0.798
|
WBC (≥ 20 vs. < 20 × 109/L)
|
1.530 (0.910–2.571)
|
0.108
|
0.949 (0.554–1.628)
|
0.851
|
FLT3-ITD (positive vs. negative)
|
1.873 (1.020–3.437)
|
0.043
|
1.998 (1.053–3.788)
|
0.034
|
NPM1 (mutated vs. wild)
|
0.913 (0.515–1.619)
|
0.755
|
0.879 (0.478–1.671)
|
0.678
|
DNMT3A (mutated vs. wild)
|
1.106 (0.615–1.989)
|
0.737
|
1.269 (0.686–2.347)
|
0.447
|
RUNX1 (mutated vs. wild)
|
1.375 (0.650–2.907)
|
0.404
|
2.253 (1.046–4.849)
|
0.038
|
TP53 (mutated vs. wild)
|
1.579 (0.565–4.411)
|
0.383
|
3.788 (1.289–11.133)
|
0.015
|
CEBPA (mutated vs. wild)
|
0.853 (0.366–1.989)
|
0.713
|
0.644 (0.256–1.620)
|
0.350
|
IDHI/IDH2 (mutated vs. wild)
|
0.761 (0.417–1.389)
|
0.374
|
0.802 (0.422–1.524)
|
0.500
|
NRAS/KRA S (mutated vs. wild)
|
1.373 (0.622–3.034)
|
0.433
|
0.658 (0.261–1.657)
|
0.374
|
MLL-PTD (mutated vs. wild)
|
6.093 (2.051–18.098)
|
0.001
|
3.106 (1.104–8.741)
|
0.032
|
Multivariate analyses
|
WBC (≥ 20 vs. < 20 × 109/L)
|
1.691 (0.973–2.940)
|
0.062
|
–
|
–
|
FLT3-ITD (positive vs. negative)
|
1.740 (0.934–3.239)
|
0.081
|
2.549 (1.306–4.975)
|
0.006
|
TP53 (mutated vs. wild)
|
2.657 (0.877–8.048)
|
0.084
|
5.841 (1.895–18.009)
|
0.002
|
RUNX1 (mutated vs. wild)
|
–
|
–
|
3.007 (1.355–6.673)
|
0.007
|
MLL-PTD (mutated vs. wild)
|
6.028 (2.001–18.158)
|
0.001
|
–
|
–
|